Association of the diplotype configuration at the N-acetyltransferase 2 gene with adverse events with co-trimoxazole in Japanese patients with systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 9, Issue 2, 2007, Pages

  Soejima, Makoto ^a   Sugiura, Tomoko ^a   Kawaguchi, Yasushi ^a   Kawamoto, Manabu ^a   Katsumata, Yasuhiro ^a   Takagi, Kae ^a   Nakajima, Ayako ^a   Mitamura, Tadayuki ^b   Mimori, Akio ^c   Hara, Masako ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JR Tokyo General Hospital   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; COTRIMOXAZOLE; IMMUNOSUPPRESSIVE AGENT; ALANINE AMINOTRANSFERASE; ANTIINFECTIVE AGENT; ASPARTATE AMINOTRANSFERASE; NAT2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATTRIBUTABLE RISK; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HUMAN; JAPANESE; LEUKOPENIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHARMACOGENOMICS; PNEUMOCYSTIS PNEUMONIA; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; ASIAN; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; DRUG EFFECT; GENETICS; HAPLOTYPE; IMMUNE DEFICIENCY; IMMUNOLOGY; MICROBIOLOGY; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALANINE TRANSAMINASE; ANTI-INFECTIVE AGENTS; ARYLAMINE N-ACETYLTRANSFERASE; ASIAN CONTINENTAL ANCESTRY GROUP; ASPARTATE AMINOTRANSFERASES; CASE-CONTROL STUDIES; COHORT STUDIES; HAPLOTYPES; HUMANS; IMMUNOCOMPROMISED HOST; LUPUS ERYTHEMATOSUS, SYSTEMIC; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 36048978699     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2134     Document Type: Article

References (38)

1. Bozzette SA Finkelstein DM Spector SA Frame P Powderly WG He W Phillips L Craven D van der Horst C Feinberg J A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group N Engl J Med 1995, 332:693-699. 10.1056/NEJM199503163321101 7854375
2. Hughes WT Rivera GK Schell MJ Thornton D Lott L Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis N Engl J Med 1987, 316:1627-1632. 3495732
3. Ogawa J Harigai M Nagasaka K Nakamura T Miyasaka N Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy Mod Rheumatol 2005, 15:91-96. 10.1007/s10156-004-0368-5 17029042
4. Straatmann A Bahia F Pedral-Sampaio D Brites C A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides Braz J Infect Dis 2002, 6:276-280. 10.1590/S1413-86702002000600002 12585970
5. Carr A Gross AS Hoskins JM Penny R Cooper DA Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulphamethoxazole in HIV-infected patients AIDS 1994, 8:333-337. 10.1097/ 00002030-199403000-00006 8031511
6. Rieder MJ Uetrecht J Shear NH Cannon M Miller M Spielberg SP Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites Ann Intern Med 1989, 110:286-289. 2913915
7. Cribb AE Miller M Leeder JS Hill J Spielberg SP Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity Drug Metab Dispos 1991, 19:900-906. 1686233
8. Carr A Tindall B Penny R Cooper DA In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV Clin Exp Immunol 1993, 94:21-25. 8403509
9. Gill HJ Hough SJ Naisbitt DJ Maggs JL Kitteringham NR Pirmohamed M Park BK The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat J Pharmacol Exp Ther 1997, 282:795-801. 9262343
10. Cribb AE Nakamura H Grant DM Miller MA Spielberg SP Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism Biochem Pharmacol 1993, 45:1277-1282. 10.1016/0006-2952(93)90280-A 8466547
11. Ilett KF Kadlubar FF Minchin RF 1998 International Meeting on the Arylamine N-Acetyltransferases: Synopsis of the workshop on nomenclature, biochemistry, molecular biology, interspecies comparisons, and role in human disease risk Drug Metab Dispos 1999, 27:957-959. 10460790
12. Hein DW McQueen CA Grant DM Goodfellow GH Kadlubar FF Weber WW Pharmacogenetics of the arylamine N-acetyltransferases: A symposium in honor of Wendell W. Weber Drug Metab Dispos 2000, 28:1425-1432. 11095579
13. Arylamine N-acetyltransferase (NAT) nomenclature. http://www.louisville.edu/medschool/pharmacology/NAT.html
14. Ohno M Yamaguchi I Yamamoto I Fukuda T Yokota S Maekura R Ito M Yamamoto Y Ogura T Maeda K Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity Int J Tuberc Lung Dis 2000, 4:256-261. 10751073
15. Tanaka E Taniguchi A Urano W Nakajima H Matsuda Y Kitamura Y Saito M Yamanaka H Saito T Kamatani N Adverse effects of sulfasalazine in patients with rheumatoid arthritis are associated with diplotype configuration at the N-acetyltransferase 2 gene J Rheumatol 2002, 29:2492-2499. 12465141
16. Grant DM Hughes NC Janezic SA Goodfellow GH Chen HJ Gaedigk A Yu VL Grewal R Human acetyltransferase polymorphisms Mutat Res 1997, 376:61-70. 9202739
17. Grant DM Tang BK Kalow W A simple test for acetylator phenotype using caffeine Br J Clin Pharmacol 1984, 17:459-464. 6721992
18. Vatsis KP Weber WW Bell DA Dupret JM Evans DA Grant DM Hein DW Lin HJ Meyer UA Relling MV Nomenclature for N-acetyltransferases Pharmacogenetics 1995, 5:1-17. 10.1097/00008571-199502000-00001 7773298
19. Tan EM Cohen AS Fries JF Masi AT McShane DJ Rothfield NF Schaller JG Talal N Winchester RJ The 1982 revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1982, 25:1271-1277. 10.1002/art.1780251101 7138600
20. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus Arthritis Rheum 1997, 40:1725. 10.1002/art.1780400928 9324032
21. Bohan A Peter JB Polymyositis and dermatomyositis (first of two parts) N Engl J Med 1975, 292:344-347. 1090839
22. Ito T Inoue E Kamatani N Association test algorithm between a qualitative phenotype and a haplotype or haplotype set using simultaneous estimation of haplotype frequencies, diplotype configurations and diplotype-based penetrances Genetics 2004, 168:2339-2348. 1448736 15611197 10.1534/genetics.103.024653
23. Furihata S Ito T Kamatani N Test of association between haplotypes and phenotypes in case-control studies: Examination of validity of the application of an algorithm for samples from cohort or clinical trials to case-control samples using simulated and real data Genetics 2006, 174:1505-1516. 1667068 16980401 10.1534/genetics.105.054452
24. Kitamura Y Moriguchi M Kaneko H Morisaki H Morisaki T Toyama K Kamatani N Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm Ann Hum Genet 2002, 66:183-193. 10.1046/ j.1469-1809.2002.00112.x 12174210
25. Ohtani T Hiroi A Sakurane M Furukawa F Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine Br J Dermatol 2003, 148:1035-1039. 10.1046/ j.1365-2133.2003.05321.x 12786839
26. Zielinska E Niewiarowski W Bodalski J Rebowski G Skretkowicz J Mianowska K Sekulska M Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants Pharm World Sci 1998, 20:123-130. 10.1023/A:1008664707825 9618736
27. Karpman E Kurzrock EA Adverse reactions of nitrofurantoin, trimethoprim and sulfamethoxazole in children J Urol 2004, 172:448-453. 10.1097/ 01.ju.0000130653.74548.d6 15247700
28. Pullar T Adverse effects of sulphasalazine Adverse Drug React Toxicol Rev 1992, 11:93-109. 1353378
29. Chave TA Mortimer NJ Sladden MJ Hall AP Hutchinson PE Toxic epidermal necrolysis: Current evidence, practical management and future directions Br J Dermatol 2005, 153:241-253. 10.1111/j.1365-2133.2005.06721.x 16086734
30. Pirmohamed M Alfirevic A Vilar J Stalford A Wilkins EG Sim E Park BK Association analysis of drug metabolizing enzyme gene polymorphisms in HIV-positive patients with co-trimoxazole hypersensitivity Pharmacogenetics 2000, 10:705-713. 10.1097/00008571-200011000-00005 11186133
31. Srivastava DS Mittal RD Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: A pilot study in north Indian population BMC Urol 2005, 5:12. 1190195 16083506 10.1186/ 1471-2490-5-12
32. Mannervik B Danielson UH Glutathione transferases: Structure and catalytic activity CRC Crit Rev Biochem 1988, 23:283-337. 3069329
33. Seidegard J Pero RW Miller DG Beattie EJ A glutathione transferase in human leukocytes as a marker for the susceptibility to lung cancer Carcinogenesis 1986, 7:751-753. 10.1093/carcin/7.5.751 3698203
34. Pemble S Schroeder KR Spencer SR Meyer DJ Hallier E Bolt HM Ketterer B Taylor JB Human glutathione S-transferase theta (GSTT1): CDNA cloning and the characterization of a genetic polymorphism Biochem J 1994, 300:271-276. 1138152 8198545
35. Arand M Muhlbauer R Hengstler J Jager E Fuchs J Winkler L Oesch F A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms Anal Biochem 1996, 236:184-186. 10.1006/abio.1996.0153 8619490
36. Nakajima T Elovaara E Anttila S Hirvonen A Camus AM Hayes JD Ketterer B Vainio H Expression and polymorphism of glutathione S-transferase in human lungs: Risk factors in smoking-related lung cancer Carcinogenesis 1995, 16:707-711. 10.1093/carcin/16.4.707 7728947
37. Dalhoff K Buus Jensen K Enghusen Poulsen H Cancer and molecular biomarkers of phase 2 Methods Enzymol 2005, 400:618-627. 16399374
38. Chan EC Lam SY Fu KH Kwong YL Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: Relationship with aberrant promoter methylation of the CDKN2A and RARB genes Cancer Genet Cytogenet 2005, 162:10-20. 10.1016/ j.cancergencyto.2005.03.008 16157195